COVID-19 vaccination-related [18F]FDG-avid lymph node in a patient with marginal zone B-cell lymphoma.

Ziolkowska, Paulina; Salyga, Alicja; Joks, Monika; Ruchala, Marek; Czepczynski, Rafal

Ziolkowska, Paulina; Salyga, Alicja; Joks, Monika; Ruchala, Marek; Czepczynski, Rafal.

Afiliação

Ziolkowska P; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland. paulina_z1@vp.pl.
Salyga A; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Joks M; Department of Nuclear Medicine, Affidea, Poznan, Poland.
Ruchala M; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Czepczynski R; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.

Nucl Med Rev Cent East Eur ; 26(0): 52-53, 2023.

Article em En | MEDLINE | ID: mdl-38966958

ABSTRACT

ABSTRACT

The [18F]FDG PET/CT is a crucial tool in the diagnostic process and monitoring of neoplastic diseases. Currently, during the global program of vaccination against COVID-19 and the possibility of axillary lymphadenopathy after this injection, the correct interpretation of PET/CT images is vitally significant and may create some difficulties. We present a case of increased uptake of [18F]FDG in an axillary lymph node in a PET/CT scan performed 2 days after the Pfizer BioNTech COVID-19 vaccine in a 48-year-old patient newly diagnosed with marginal zone B-cell lymphoma.

Palavras-chave

COVID-19; PET/CT; marginal zone B-cell lymphoma; staging; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nucl Med Rev Cent East Eur Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google